Our most recent newsletter includes the list of trainees who were awarded a travel award for the Montreal meeting and more! Read it now:
CAN Connection - Spring 2014
Air France's commitment to supporting biomedical research is to be commended. Their continued commitment to transporting live animals used for research is very important to neuroscientists.
We invite all our members and neuroscientists everywhere to write to Air France to thank them for this important support. Read more here
The Canadian Association for Neuroscience is proud to announce Dr. Shayna Rosenbaum, from York University, is the CAN 2013 Young Investigator Awardee.
Read Dr. Shayna Rosenbaum's profile and find representative publications on the 2013 Award page.
Have you listened to the "Think about it: A user's guide to the brain" radio series this Summer on the CBC? All shows are still available: Think about it website
Read "A Big Brainstorm is underway in Neuroscience", by Ivan Semeniuk, in the Globe and Mail (includes interviews with CAN members David Kaplan, Tim Murphy and Yves De Koninck).
Also on the CBC, Henry Friensen Prize winner Marc Tessier
Lavigne was interviewed by Paul Kennedy, host of Ideas.
Listen to Building Brains.
Visit our new Funding Opportunities webpage.
The page currently features new funding opportunities from :
Brain Canada - Platform Support Grants
The W. Garfield Weston Foundation 2013 Rapid Response:
Neurodegenerative Diseases of Aging grant program,
International Foundation for Research in Paraplegia.
Sam David, President of the Canadian Association for Neuroscience, has given a feature interview for the magazine International Innovation.
"International Innovation is the leading global dissemination resource for the wider scientific, technology and research communities, dedicated to disseminating the latest science, research and technological innovations on a global level. More information and a complimentary subscription offer to the publication can be found here"
People with schizophrenia often misinterpret what they see and experience in the world. New research provides insight into the brain mechanisms that might be responsible for this misinterpretation. The study from the Montreal Neurological Institute and Hospital – The Neuro – at McGill University and McGill University Health Centre, reveals that certain errors in visual perception in people with schizophrenia are consistent with interference or ‘noise’ in a brain signal known as a corollary discharge. +++ »
It may now be possible to identify the first-stage Parkinson’s patients who will go on to develop dementia, according to a study conducted at the Institut universitaire de gériatrie de Montréal by Dr. Oury Monchi, PhD, and his postdoctoral student, Dr. Alexandru Hanganu, MD, PhD, both of whom are affiliated with Université de Montréal. These findings were published in the journal Brain. +++ »
Scientists have uncovered how inflammation and lack of oxygen conspire to cause brain damage in conditions such as stroke and Alzheimer’s disease.
The discovery, published today in Neuron, brings researchers a step closer to finding potential targets to treat neurodegenerative disorders. +++ »
A new University of British Columbia study identifies an important molecular change that occurs in the brain when we learn and remember.
Published this month in Nature Neuroscience, the research shows that learning stimulates our brain cells in a manner that causes a small fatty acid to attach to delta-catenin, a protein in the brain. This biochemical modification is essential in producing the changes in brain cell connectivity associated with learning, the study finds. +++ »
A new technique that targets proteins that cause disease and destroys “bad apples” in the cell has been developed by researchers at the University of British Columbia’s Brain Research Centre, part of Vancouver Coastal Health Research Institute.
The findings, published this month in Nature Neuroscience, has important implications for a variety of diseases, including Alzheimer’s, Huntington’s, stroke and even cancers, the researchers say. +++ »
A study led by University of British Columbia and Vancouver Coastal Health Research Institute researchers has revealed how the fatal neurodegenerative disease amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is transmitted from cell to cell, and suggests the spread of the disease could be blocked.
“This work identifies an important piece of the puzzle in determining how the disease is transmitted throughout the nervous system,” says lead investigator Dr. Neil Cashman, UBC’s Canada Research Chair in Neurodegeneration and Protein Misfolding. “By understanding how this occurs, we can devise the best ways to stop the progressive neurological damage seen in ALS.” +++ »